1Rojewski MT;Baldus C;Knauf W.Dual effects of arsenic trioxide (As2O3) on non-acute promyelocytic leukaemia myeloid cell lines:induction of apoptosis and inhibition of proliferation[J],2002(03).
1ZHOU Jin1,MENG Ran1,2,SUI Xinhua2,LI Wenbin3 & YANG Baofeng1 1.The First Hospital of Harbin Medical University,Harbin 150001,China,2. Shijitan Hospital,The Ninth Clinical Medical College of Peking University,Beijing 100038,China,3. Xuanwu Hospital,Capital University of Medical Sciences,Beijing 100053,China.Various tolerances to arsenic trioxide between human cortical neurons and leukemic cells[J].Science China(Life Sciences),2006,49(6):567-572. 被引量:6
5Gore S D, Gojo I, Sekeres M A, et al. Single cycle of arsenic trioxidebased consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemia[J]. J Clin Oncol, 2010, 28(6):1047-1053.
6Zhou J,Zhang Y,Li J,et al.Single-agent arsenic trioxide in the treatmentof children with newly diagnosed acute promyelocytic leukemia,Blo od,2010,115:1697-1702.
7Ling Y H,Jmng J D, Holland J F, et al.Arsenic trioxide producespolymerization of microtubules and mitotic arrest before apoptosis inhuman tumor cell lines[J].Mol Pharmacol, 2002,62 ( 3 ) : 529-538.
8Park W H, Seol J G, Kim E S, et al.Arsenic trioxide-mediatedgrowth inhibition in MC/Car myeloma cells via cell cycle arrest inassociation with induction of cyclin-dependent kinase inhibitor,p21, and apoptosis[J].Cancer Res, 2000,60 ( 11 ) : 3065-3071.